Boothbay Fund Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-30,000
| Closed | -$13.1K | – | 2336 |
|
|
2022
Q4 | $13.1K | Hold |
30,000
| – | – | ﹤0.01% | 1686 |
|
|
2022
Q3 | $8K | Hold |
30,000
| – | – | ﹤0.01% | 1895 |
|
|
2022
Q2 | $11K | Buy |
+30,000
| New | +$11K | ﹤0.01% | 1926 |
|
|
2020
Q4 | – | Sell |
-38,028
| Closed | -$176K | – | 1343 |
|
|
2020
Q3 | $176K | Sell |
38,028
-772
| -2% | -$3.57K | 0.01% | 829 |
|
|
2020
Q2 | $109K | Hold |
38,800
| – | – | 0.01% | 750 |
|
|
2020
Q1 | $95K | Hold |
38,800
| – | – | 0.01% | 634 |
|
|
2019
Q4 | $199K | Sell |
38,800
-7,189
| -16% | -$36.9K | 0.02% | 608 |
|
|
2019
Q3 | $297K | Hold |
45,989
| – | – | 0.03% | 487 |
|
|
2019
Q2 | $287K | Buy |
45,989
+2,354
| +5% | +$14.7K | 0.03% | 442 |
|
|
2019
Q1 | $464K | Buy |
43,635
+17,681
| +68% | +$188K | 0.05% | 321 |
|
|
2018
Q4 | $207K | Buy |
25,954
+23,716
| +1,060% | +$189K | 0.03% | 409 |
|
|
2018
Q3 | $43K | Hold |
2,238
| – | – | ﹤0.01% | 622 |
|
|
2018
Q2 | $40K | Buy |
+2,238
| New | +$40K | ﹤0.01% | 586 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 774 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 743 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 808 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 905 |
|